Tim Hendrickson
Plus aucun poste en cours
Fortune : 197 775 $ au 31/03/2024
Profil
Tim Hendrickson worked as a Senior Director-Finance at Cubist Pharmaceuticals Canada, Inc. from 2014 to 2015.
He then worked as the Chief Financial Officer at HLS Therapeutics, Inc. from 2018 to 2024.
Hendrickson holds an MBA from the Rotman School of Management and an undergraduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
HLS THERAPEUTICS, INC.
0,21% | 08/11/2023 | 67 500 ( 0,21% ) | 197 775 $ | 31/03/2024 |
Anciens postes connus de Tim Hendrickson
Sociétés | Poste | Fin |
---|---|---|
HLS THERAPEUTICS INC. | Director of Finance/CFO | 26/01/2024 |
Cubist Pharmaceuticals Canada, Inc.
Cubist Pharmaceuticals Canada, Inc. Drugstore ChainsRetail Trade Cubist Pharmaceuticals Canada, Inc. operates pharmacies. | Director of Finance/CFO | 01/08/2015 |
Formation de Tim Hendrickson
Rotman School of Management | Masters Business Admin |
University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HLS THERAPEUTICS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Cubist Pharmaceuticals Canada, Inc.
Cubist Pharmaceuticals Canada, Inc. Drugstore ChainsRetail Trade Cubist Pharmaceuticals Canada, Inc. operates pharmacies. | Retail Trade |